CN Patent

CN104042572A — 一种含福沙匹坦二甲葡胺的注射用组合物及其制备方法

Assigned to Jiangsu Aosaikang Pharmaceutical Co Ltd · Expires 2014-09-17 · 12y expired

What this patent protects

本发明提供了一种含福沙匹坦二甲葡胺的药物组合物及其制备方法。本发明药物组合物由福沙匹坦二甲葡胺、乳糖、依地酸二钠、吐温-80组成；其中福沙匹坦二甲葡胺、依地酸二钠、吐温-80、乳糖的质量比为188~245.3:14.4~18.8:57.5~75:287.5~375；所述组合物由含有乙醇的水溶液冷冻干燥而得。本发明提供的制备方法工艺简单可控，节约能耗。由本发明提供的制备方法获得的药物组合物质量稳定，保证了临床用药的安全性。

USPTO Abstract

本发明提供了一种含福沙匹坦二甲葡胺的药物组合物及其制备方法。本发明药物组合物由福沙匹坦二甲葡胺、乳糖、依地酸二钠、吐温-80组成；其中福沙匹坦二甲葡胺、依地酸二钠、吐温-80、乳糖的质量比为188~245.3:14.4~18.8:57.5~75:287.5~375；所述组合物由含有乙醇的水溶液冷冻干燥而得。本发明提供的制备方法工艺简单可控，节约能耗。由本发明提供的制备方法获得的药物组合物质量稳定，保证了临床用药的安全性。

Drugs covered by this patent

fosaprepitant-dimeglumine (FOSAPREPITANT DIMEGLUMINE)

Patent Metadata

Patent number: CN104042572A
Jurisdiction: CN
Classification: —
Expires: 2014-09-17
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Aosaikang Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.